1994
DOI: 10.1073/pnas.91.17.8180
|View full text |Cite
|
Sign up to set email alerts
|

A regulatory system for use in gene transfer.

Abstract: We recently have demonstrated that a C-terminal deletion mutant

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

4
299
1

Year Published

1997
1997
2007
2007

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 419 publications
(304 citation statements)
references
References 30 publications
4
299
1
Order By: Relevance
“…3,[25][26][27][28] Some major advantages of the Tet-on system compared to the other gene regulation systems are a well-known safety profile, easy availability and good tissue penetration of the regulating drug dox. Bacterial origin of the Tet-on elements assures minimal interference with endogenous physiological processes of the eukaryotic cells.…”
Section: Discussionmentioning
confidence: 99%
“…3,[25][26][27][28] Some major advantages of the Tet-on system compared to the other gene regulation systems are a well-known safety profile, easy availability and good tissue penetration of the regulating drug dox. Bacterial origin of the Tet-on elements assures minimal interference with endogenous physiological processes of the eukaryotic cells.…”
Section: Discussionmentioning
confidence: 99%
“…[41][42][43] They all involve the drugdependent recruitment of a transcriptional activation domain to a basal promoter driving the gene of interest but differ in the mechanism of recruitment. [41][42][43][44][45] In the mifepristone system, drug-regulated transcription is achieved by fusing a heterologous DNA-binding domain of yeast GAL4 protein and activation domain of VP-16 or NF-B p65 proteins to a mutant human progesterone receptor that is unaffected by endogenous hormones but is activated by synthetic antiprogestins at doses sufficiently low to avoid side-effects in human. 45,46 The properties of the mifepristone-regulated system have been investigated in transgenic animals and naked DNA plasmid in muscles.…”
mentioning
confidence: 99%
“…[41][42][43][44][45] In the mifepristone system, drug-regulated transcription is achieved by fusing a heterologous DNA-binding domain of yeast GAL4 protein and activation domain of VP-16 or NF-B p65 proteins to a mutant human progesterone receptor that is unaffected by endogenous hormones but is activated by synthetic antiprogestins at doses sufficiently low to avoid side-effects in human. 45,46 The properties of the mifepristone-regulated system have been investigated in transgenic animals and naked DNA plasmid in muscles. [47][48][49][50] Burcin et al 45 have incorporated this system into a gutless adenovirus with a human growth hormone target gene.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…While current inducible systems, such as RU486 and chemical inducers of dimerization (CID), have improved earlier inducible models (Gossen et al, 1995) (Wang et al, 1994), no single system is perfect at present. One potential drawback of these systems is leakage of transgene expression, causing limitations of each system.…”
mentioning
confidence: 99%